Zutectra® is a hepatitis B immunoglobulin for subcutaneous (s.c.) use. It is licensed for the prevention of hepatitis B virus (HBV) re-infection in HBsAg and HBV-DNA negative adult patients at least one week after liver transplantation for hepatitis B induced liver failure. HBV DNA negative status should be confirmed within the last 3 months prior to OLT. Patients should be HBsAg negative before treatment start.

Features and Benefits

  • Subcutaneous Use Only
  • Ready to Use Pack of 5 x 1ml prefilled syringe
  • One pre-filled syringe of 1ml contains Human hepatitis B immunoglobulin 500IU
  • Treatment in home environment
  • Easy to Use
  • Human protein 150 mg/ml of which at least 96 % is IgG, with a content of antibodies to hepatitis B virus surface antigen (HBs) of 500 IU/ml.

Zutectra Brochure